ELVN
Enliven Therapeutics Inc.
42.40$
-6.8%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | 17.5% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| – | 82.5% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| – | 4,069.3% | – | – | – | 6,558.2% | – | – | – | – | – | – | – | |
| – | 1,096.4% | – | – | – | 1,953.2% | – | – | – | – | – | – | – | |
| – | 5,165.7% | – | – | – | 8,511.4% | – | – | – | – | – | – | – | |
| – | -5,165.7% | – | – | – | -8,511.4% | – | – | – | – | – | – | – | |
| – | 385.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -4,402.3% | – | – | – | -7,335.4% | – | – | – | – | – | – | – | |
| – | 1,178.6% | – | – | – | -158.2% | – | – | – | – | – | – | – | |
| – | -4,402.3% | – | – | – | -7,335.4% | – | – | – | – | – | – | – | |
| – | -4,384.5% | – | – | – | -7,310.1% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.